# OSU K12 Training Grant in Oncology

> **NIH NIH K12** · OHIO STATE UNIVERSITY · 2022 · $810,000

## Abstract

Project Summary/Abstract
The goal of this proposal is to mentor and train junior faculty investigators in laboratory and/or clinical translational
cancer research. Implementation of this K12 program for the career development of laboratory-based
(PhD/DVM/MD) and clinical (MD or MD/PhD) translational scientists in diverse areas of oncology will ensure a
cadre of highly-trained individuals who can communicate across disciplines to drive new advancements in how
we approach cancer diagnosis and management. This K12 program from The Ohio State University
Comprehensive Cancer Center (OSUCCC) continues its focus on early drug development, but now also extends
to cancer prevention, control and survivorship research. The OSUCCC is clearly dedicated to research education
and providing outstanding career development and mentoring opportunities to promising junior faculty. The
Divisions of Hematology, Medical Oncology, Radiation Oncology, and Surgical Oncology each have robust
programs that are continuously recruiting new junior faculty to facilitate expansion of our cancer program.
Recruitment efforts also emphasize the inclusion of women, minorities and underserved groups to increase
diversity. This K12 grant fills an important need by extending research education, career development and
mentoring to junior faculty interested in establishing academic research careers. It is the only OSUCCC training
program dedicated solely to faculty-level career development in cancer research, and thus has no overlap with
any of the OSU T32 training grants, which focus on fellows. This strategy ensures continuity in training and
provides individuals a structured path to become independent clinical or translational investigators. The quality
of this K12 program and its success in training cancer researchers is exemplified by the career trajectories of
past trainees, their papers, grants, clinical trials and other scholarly activities that have driven new discoveries.
The continued success of this program will be ensured by the overall strength and direction of the OSUCCC, as
demonstrated by its recent peer review score of 10 (exceptional), financial support of this K12 program by the
OSUCCC and by different Divisions and Departments, and the enormous breadth of expertise and resources
available at OSU. This K12 program seeks to train two types of investigators. The first includes MD and/or PhD
faculty who have outstanding basic science training and want to pursue laboratory-based investigation related
to applied research in experimental therapeutics, cancer prevention, control, and survivorship. The second group
includes MD or MD/PhD faculty who want to pursue clinical research in experimental therapeutics and cancer
prevention, control, or survivorship. Training plans are tailored to each individual trainee to facilitate their
success, with inclusion of a robust evaluation program to assess the effectiveness of the K12. The value of the
OSU K12 program is best demonstrate...

## Key facts

- **NIH application ID:** 10477991
- **Project number:** 5K12CA133250-14
- **Recipient organization:** OHIO STATE UNIVERSITY
- **Principal Investigator:** WILLIAM E. CARSON
- **Activity code:** K12 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $810,000
- **Award type:** 5
- **Project period:** 2008-09-09 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10477991

## Citation

> US National Institutes of Health, RePORTER application 10477991, OSU K12 Training Grant in Oncology (5K12CA133250-14). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10477991. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*